Tenderwize
Back to tender search

Open-house rebate agreements for Betamethason and antibiotics

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 226 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Betamethason und Antibiotika, ATC D07CC01

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

Submission by original documents is required and electronic submission is not allowed, which increases delivery and tim...

The buyer may later replace the open-house agreements with exclusive rebate agreements, causing automatic termination o...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive rebate agreements for pharmaceutical products with active substance Betamethason and antibiotics, ATC D07CC01.
  • Open-house model with uniform terms for all participants; no individual negotiations.
Show full summary

This is an open-house pharmaceutical supply notice by AOK Rheinland-Pfalz/Saarland for non-exclusive rebate agreements on Betamethason and antibiotics (ATC D07CC01), with a 24-month maximum term and monthly entry possible. The notice explicitly states that it is not a public procurement contract under the procurement rules, but it is published for transparency. No contract value is provided. Submission is by original documents only; electronic submission is not allowed. The notice excludes medicines listed as children’s medicines under the BfArM list (§ 35 Abs. 5a SGB V).

Risks

Submission by original documents is required and electronic submission is not allowed, which increases delivery and tim...

The buyer may later replace the open-house agreements with exclusive rebate agreements, causing automatic termination o...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only authorised and marketable medicines in Germany may be supplied.

Administrative

  • If a medicine is not yet listed in Lauer-Taxe at submission time, an AMIce public extract must be provided with the required information.
  • If the AMIce extract is incomplete or outdated, supplementary evidence such as approval documents, change notifications, or an affidavit must be submitted.

Buyer

Lots (1)

LOT-0001

Open-house rebate agreements for Betamethason and antibiotics

Single lot open-house model for non-exclusive rebate agreements for medicines with the stated active substance/ATC D07CC01. The contracting buyer offers the same conditions to all interested pharmaceutical companies, with no individual negotiations. Contracts can start on the first day of each month within the 24-month period, earliest 2025-06-01, and end no later than 24 months after the earliest start date. The notice says the buyer may replace these open-house agreements with exclusive agreements later. Medicines listed as children’s medicines under the BfArM list are excluded. Eligibility-related supply proof is required for marketed medicines in Germany.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
237226-2025

Documents (1)

Similar tenders